Our read is that taking progesterone is well supported for various health benefits, including managing PMS, improving sleep, and protecting the uterine lining.
Our read is that progesterone is well supported for a range of applications, from ameliorating PMS symptoms and improving sleep to protecting the endometrial lining in women with a uterus.
Experts note its use in HRT for anxiety and sleep, its role in balancing free androgen levels in men on TRT, and its potential in preventing Alzheimer's disease when timed correctly around menopause.
However, individual responses vary, and some individuals may experience negative mood impacts or other adverse reactions.
For PMS symptoms, taking oral progesterone for seven days is suggested. For inducing a withdrawal bleed, micronized progesterone at 200mg for 5 days is mentioned, or medroxyprogesterone acetate at 5-10mg for 5 days. A typical starting dose for oral progesterone is 100mg, potentially increasing to 200mg if estrogen doses are higher. After inducing a withdrawal bleed, letrozole is started on day three to seven of the cycle to ripen the follicle.
Peter Attia notes that for a subset of women, progesterone can negatively impact mood, leading to depression or severe irritability (1x). Peter Attia also points out that the Women's Health Initiative study, which found a 25% increased risk of breast cancer, used conjugated equine estrogen and medroxyprogesterone acetate, not bio-identical estradiol and micronized progesterone, suggesting its findings were misleading (2x). Peter Attia also states that oral contraceptives that do not contain 17 beta-estradiol or progesterone may compromise long-term health benefits like bone density (1x). Peter Attia and Andrew Huberman mention that not all women can tolerate oral progesterone, and for some, it can cause significant adverse psychological effects (2x). Peter Attia notes that approximately one-third of patients experience significant benefits from micronized progesterone, while another third notice no effect, and the final third are highly sensitive and may experience adverse reactions (1x). Peter Attia also states that some individuals can have extreme reactions or progesterone allergies, leading to side effects like excessive sleepiness or bloating (1x).
It is unknown if bioidentical micronized progesterone would increase breast cancer risk similarly to MPA, although some observational studies suggest a lesser increase (Peter Attia, 1x). Whether 100mg of progesterone taken systemically is sufficient to oppose estrogen requires more data, and patient bleeding may indicate a need for more progesterone (Peter Attia, 1x).
Mechanistic and trial evidence converge on a real, replicable effect.
Taking oral progesterone for seven days can ameliorate PMS symptoms.
Progestogenic activity acts as a GABA agonist and improves sleep.
Finding a woman's individual optimal dose of progesterone is key, with some tolerating 50-100mg well.
A progesterone-coated IUD can be used for local protection in the uterus while maintaining systemic estrogen therapy if oral progesterone is not tolerated.
The headline effect shrinks once you account for trial quality.
Most of the support comes from short or small studies.
Most of the support comes from short or small studies.
The headline effect shrinks once you account for trial quality.
Confounding and publication bias inflate the apparent benefit.